Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12528836 | Dosing regimens | 🖼🧊📄§ | 2026-01-20 | 2043-12-21 | 0 | 31 |
| 12527788 | Defining RNA-small molecule affinity landscapes enables design of a small molecule inhibitor of an oncogenic non-coding RNA | 🖼🧊📄§ | 2026-01-20 | 2038-02-16 | 0 | 31 |
| 12527837 | Peptide for use in the prevention and/or treatment of a disease caused by a virus affecting the respiratory tract | 🖼🧊📄§ | 2026-01-20 | 2041-05-19 | 0 | 31 |
| 12527805 | Compositions and methods for treating CNS disorders | 🖼🧊📄§ | 2026-01-20 | 2045-01-03 | 0 | 31 |
| 12528772 | Formulations of T-type calcium channel modulators and methods of use thereof | 🖼🧊📄§ | 2026-01-20 | 2040-07-10 | 0 | 31 |
| 12528871 | Universal immune cells for cancer immunotherapy | 🖼🧊📄§ | 2026-01-20 | 2042-01-05 | 0 | 31 |
| 12527858 | MVA vectors for expressing multiple cytomegalovirus (CMV) antigens and use thereof | 🖼🧊📄§ | 2026-01-20 | 2040-11-11 | 0 | 31 |
| 12529034 | Wnt-activated adipose-derived stem cell apparatuses, methods and systems | 🖼🧊📄§ | 2026-01-20 | 2039-09-19 | 0 | 31 |
| 12528793 | Compounds for treating tuberculosis | 🖼🧊📄§ | 2026-01-20 | 2040-11-26 | 0 | 31 |
| 12527785 | Renin-angiotensin-aldosterone system (RAAS) inhibitors in the treatment of pancreatic ductal carcinoma | 🖼🧊📄§ | 2026-01-20 | 2043-01-10 | 0 | 31 |
| 12528850 | TGF-β polypeptides | 🖼🧊📄§ | 2026-01-20 | 2043-04-12 | 0 | 31 |
| 12528868 | CD1a antibodies and uses thereof | 🖼🧊📄§ | 2026-01-20 | 2043-07-19 | 0 | 31 |
| 12527760 | Synthesis of pro-resolving analogs and compositions therefor | 🖼🧊📄§ | 2026-01-20 | 2040-07-23 | 0 | 31 |
| 12527857 | Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof | 🖼🧊📄§ | 2026-01-20 | 2043-10-20 | 0 | 31 |
| 12527772 | Pharmaceutical combination comprising ponesimod | 🖼🧊📄§ | 2026-01-20 | 2043-06-27 | 0 | 31 |
| 12528858 | Humanized antibodies that recognize alpha-synuclein | 🖼🧊📄§ | 2026-01-20 | 2042-04-26 | 0 | 31 |
| 12527813 | Methods to stabilize and reverse atherosclerotic lesions by sulfated polysaccharides | 🖼🧊📄§ | 2026-01-20 | 2041-10-05 | 0 | 31 |
| 12528863 | Claudin-6 binding molecules and uses thereof | 🖼🧊📄§ | 2026-01-20 | 2040-07-10 | 0 | 31 |
| 12527811 | Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion | 🖼🧊📄§ | 2026-01-20 | 2042-12-14 | 0 | 31 |
| 12528869 | Treatment of non-small cell lung cancer with EGFR mutations | 🖼🧊📄§ | 2026-01-20 | 2041-08-25 | 0 | 31 |
| 12527873 | Glycocalyx mimetic coatings | 🖼🧊📄§ | 2026-01-20 | 2041-09-09 | 0 | 31 |
| 12529105 | Application of BAZ2B gene as target in slowing aging | 🖼🧊📄§ | 2026-01-20 | 2039-12-27 | 0 | 31 |
| 12527824 | Strain of Bifidobacterium animalis subsp. lactis HEM20-01 and composition for treating depression, comprising the same or its culture fluid | 🖼🧊📄§ | 2026-01-20 | 2041-12-14 | 0 | 31 |
| 12528878 | Treatment of IgE-mediated diseases with antibodies that specifically bind CD38 | 🖼🧊📄§ | 2026-01-20 | 2043-06-05 | 0 | 31 |
| 12527876 | Insulin-like growth factor-chemotherapeutic conjugate for treating myelodysplastic syndrome | 🖼🧊📄§ | 2026-01-20 | 2042-03-24 | 0 | 31 |
| 12527798 | Preservation of immune response during chemotherapy regimens | 🖼🧊📄§ | 2026-01-20 | 2042-12-01 | 0 | 31 |
| 12528860 | Polypeptides comprising immunoglobulin single variable domains targeting TNFα and IL-23 | 🖼🧊📄§ | 2026-01-20 | 2042-04-25 | 0 | 31 |
| 12527773 | Flavi-block: a pan-flavivirus inhibitor | 🖼🧊📄§ | 2026-01-20 | 2040-10-15 | 0 | 31 |
| 12528872 | De novo binding domain containing polypeptides and uses thereof | 🖼🧊📄§ | 2026-01-20 | 2040-03-20 | 0 | 31 |
| 12527874 | Bioorthogonal compositions | 🖼🧊📄§ | 2026-01-20 | 2041-12-17 | 0 | 31 |
| 12527758 | Use of itaconate and its derivatives/analogues to induce hair growth | 🖼🧊📄§ | 2026-01-20 | 2040-10-29 | 0 | 31 |
| 12527812 | Esophageal stricture suppressing agent | 🖼🧊📄§ | 2026-01-20 | 2039-05-08 | 0 | 31 |
| 12528880 | Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack | 🖼🧊📄§ | 2026-01-20 | 2041-01-12 | 0 | 31 |
| 12528903 | Block copolymer and micelle compositions and methods of use thereof | 🖼🧊📄§ | 2026-01-20 | 2041-03-10 | 0 | 31 |
| 12527862 | Bactericidal/permeability increasing protein for use in a method of immunization, preferably as an adjuvant in a method of vaccination | 🖼🧊📄§ | 2026-01-20 | 2039-05-09 | 0 | 31 |
| 12527757 | Nanoemulsion of 18BETA-glycyrrhetinic acid | 🖼🧊📄§ | 2026-01-20 | 2040-08-07 | 0 | 31 |
| 12527789 | Inhibition of a tripartite VOR protein complex in multicellular organisms | 🖼🧊📄§ | 2026-01-20 | 2039-06-27 | 0 | 31 |
| 12529056 | Compositions and methods of treating facioscapulohumeral muscular dystrophy | 🖼🧊📄§ | 2026-01-20 | 2044-05-09 | 0 | 31 |
| 12527835 | Brevican-binding peptides for brain tumor imaging | 🖼🧊📄§ | 2026-01-20 | 2039-10-01 | 0 | 31 |
| 12529037 | M1 virus mutant and use thereof | 🖼🧊📄§ | 2026-01-20 | 2040-05-31 | 0 | 31 |
| 12527865 | haNK cetuximab combinations and methods | 🖼🧊📄§ | 2026-01-20 | 2042-09-01 | 0 | 31 |
| 12528776 | Composition and method for treating dermatological disorders using retinamides | 🖼🧊📄§ | 2026-01-20 | 2040-12-18 | 0 | 31 |
| 12527823 | Generation of kidney glomerular specific endothelial cells and methods of use | 🖼🧊📄§ | 2026-01-20 | 2040-11-20 | 0 | 31 |
| 12528825 | Compounds and uses thereof | 🖼🧊📄§ | 2026-01-20 | 2041-01-29 | 0 | 31 |
| 12527814 | Treatment of an ocular infection, composition and methods thereof | 🖼🧊📄§ | 2026-01-20 | 2040-12-01 | 0 | 31 |
| 12527886 | Radiopharmaceuticals and composition for thrombus imaging | 🖼🧊📄§ | 2026-01-20 | 2041-03-24 | 0 | 31 |
| 12527838 | Combination therapies comprising an agent that blocks the interaction between CD47 and SIRPα for treating gastric or gastroesphageal junction cancel | 🖼🧊📄§ | 2026-01-20 | 2043-01-13 | 0 | 31 |
| 12527818 | Platinum-based chemotherapy, mast binding agents, glucocorticoid receptor (GR) binding agents, and/or HSP90 binding agents for uses in treating cancer | 🖼🧊📄§ | 2026-01-20 | 2040-07-10 | 0 | 31 |
| 12527859 | Vaccine composition for chickenpox or Varicella Zoster and method of using same | 🖼🧊📄§ | 2026-01-20 | 2041-09-02 | 0 | 31 |
| 12527827 | Compositions for preventing or treating cancer comprising extracts of Asarum maculatum nakai | 🖼🧊📄§ | 2026-01-20 | 2042-10-07 | 0 | 31 |